Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (85)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Charloux, A
Right arrow Articles by Kreisman, H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Charloux, A
Right arrow Articles by Kreisman, H
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology, Vol 26, 14-23, Copyright © 1997 by International Epidemiological Association


ARTICLES

The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma

A Charloux, E Quoix, N Wolkove, D Small, G Pauli and H Kreisman
Pulmonary Division, Jewish General Hospital, McGill University, Montreal, (Quebec), Canada.

Lung adenocarcinoma is the most common cell type in females (smokers or non-smokers) and in non-smoking males. Its incidence has been increasing in younger cohorts of males and females until very recent years. Changes in classification and in pathological techniques account for some of this increase. In females and non-smoker males, the increase could be partly due to a detection bias in former studies. Nevertheless, successive cohorts over time seem more likely to develop adenocarcinoma and less likely to develop squamous cell carcinoma. These differences between birth cohorts suggest that the increasing incidence of adenocarcinoma is not only due to changes in pathological diagnosis. Geographical differences are also observed: in Europe, the squamous cell type still predominates and an increase in incidence of adenocarcinoma has only been reported in the Netherlands. In Asia, in the 1960s and 1970s, the proportion of adenocarcinoma was higher than in North America or Europe and seems to be increasing. To what extent these differences are due to differences. In establishing diagnosis remains unknown. Despite these biases in temporal and geographical trends detailed in this review, there has probably been a true increase in incidence of adenocarcinoma. An explanation for this should be sought in studies on detailed smoking history and passive smoking exposure, occupational exposure, diet and cooking, pollution and other environmental factors.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
J. D.F. Licchesi, W. H. Westra, C. M. Hooker, and J. G. Herman
Promoter Hypermethylation of Hallmark Cancer Genes in Atypical Adenomatous Hyperplasia of the Lung
Clin. Cancer Res., May 1, 2008; 14(9): 2570 - 2578.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. R. Pereira-Faca, R. Kuick, E. Puravs, Q. Zhang, A. L. Krasnoselsky, D. Phanstiel, J. Qiu, D. E. Misek, R. Hinderer, M. Tammemagi, et al.
Identification of 14-3-3{theta} as an Antigen that Induces a Humoral Response in Lung Cancer
Cancer Res., December 15, 2007; 67(24): 12000 - 12006.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. J. Alberg, J. G. Ford, and J. M. Samet
Epidemiology of Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 29S - 55S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
F. Chen, W. F. Bina, and P. Cole
Declining Incidence Rate of Lung Adenocarcinoma in the United States
Chest, April 1, 2007; 131(4): 1000 - 1005.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S Raimondi, V Paracchini, H Autrup, J. Barros-Dios, S Benhamou, P Boffetta, M. Cote, I. Dialyna, V Dolzan, R Filiberti, et al.
Meta- and Pooled Analysis of GSTT1 and Lung Cancer: A HuGE-GSEC Review
Am. J. Epidemiol., December 1, 2006; 164(11): 1027 - 1042.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J Cadranel, D Garfield, A Lavole, M Wislez, B Milleron, and C Mayaud
Lung cancer in HIV infected patients: facts, questions and challenges.
Thorax, November 1, 2006; 61(11): 1000 - 1008.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. Govindan, N. Page, D. Morgensztern, W. Read, R. Tierney, A. Vlahiotis, E. L. Spitznagel, and J. Piccirillo
Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results Database
J. Clin. Oncol., October 1, 2006; 24(28): 4539 - 4544.
[Abstract] [Full Text] [PDF]


Home page
Tobacco ControlHome page
N. Gray
The consequences of the unregulated cigarette.
Tob. Control, October 1, 2006; 15(5): 405 - 408.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
T. Okamoto, R. Maruyama, R. Suemitsu, Y. Aoki, H. Wataya, M. Kojo, and Y. Ichinose
Prognostic value of the histological subtype in completely resected non-small cell lung cancer
Interactive CardioVascular and Thoracic Surgery, August 1, 2006; 5(4): 362 - 366.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Chao, Z.-F. Zhang, J. Berthiller, P. Boffetta, and M. Hashibe
NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Pro187Ser Polymorphism and the Risk of Lung, Bladder, and Colorectal Cancers: a Meta-analysis.
Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 979 - 987.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. Guo, K. Higashi, Y. Ueda, M. Oguchi, T. Takegami, H. Toga, T. Sakuma, H. Yokota, S. Katsuda, H. Tonami, et al.
Microvessel Density: Correlation with 18F-FDG Uptake and Prognostic Impact in Lung Adenocarcinomas
J. Nucl. Med., March 1, 2006; 47(3): 419 - 425.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. H. Yun, M. K. Lim, K. W. Jung, J.-M. Bae, S. M. Park, S. A. Shin, J. S. Lee, and J.-G. Park
Relative and Absolute Risks of Cigarette Smoking on Major Histologic Types of Lung Cancer in Korean Men
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2125 - 2130.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. J. Alberg, M. V. Brock, and J. M. Samet
Epidemiology of Lung Cancer: Looking to the Future
J. Clin. Oncol., May 10, 2005; 23(14): 3175 - 3185.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. R. Brooks, J. H.M. Austin, R. T. Heelan, M. S. Ginsberg, V. Shin, S. H. Olson, J. E. Muscat, and S. D. Stellman
Influence of Type of Cigarette on Peripheral versus Central Lung Cancer
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 576 - 581.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. Butkiewicz, O. Popanda, A. Risch, L. Edler, H. Dienemann, V. Schulz, K. Kayser, P. Drings, H. Bartsch, and P. Schmezer
Association between the Risk for Lung Adenocarcinoma and a (-4) G-to-A Polymorphism in the XPA Gene
Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2242 - 2246.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C.-K. Toh, E.-H. Wong, W.-T. Lim, S.-S. Leong, K.-W. Fong, J. Wee, and E.-H. Tan
The Impact of Smoking Status on the Behavior and Survival Outcome of Patients With Advanced Non-small Cell Lung Cancer: A Retrospective Analysis
Chest, December 1, 2004; 126(6): 1750 - 1756.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. Yanagitani, T. Kohno, J.-G. Kim, H. Kunitoh, T. Tamura, Y. Takei, S. Tsuchiya, R. Saito, and J. Yokota
Identification of D19S246 as a Novel Lung Adenocarcinoma Susceptibility Locus by Genome Survey with 10-cM Resolution Microsatellite Markers
Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 366 - 371.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Sioris, R. Jarvenpaa, P. Kuukasjarvi, H. Helin, S. Saarelainen, and M. Tarkka
Comparison of computed tomography and systematic lymph node dissection in determining TNM and stage in non-small cell lung cancer
Eur. J. Cardiothorac. Surg., March 1, 2003; 23(3): 403 - 408.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
F. Cave-Riant, B. Cuillerier, M. Beau-Faller, N. Martinet, F. Alla, C. Bronner, A. Schneider, P. Oudet, and M. P. Gaub
Association of Genetic Defects in Primary Resected Lung Adenocarcinoma Revealed by Targeted Allelic Imbalance Analysis
Am. J. Respir. Cell Mol. Biol., October 1, 2002; 27(4): 495 - 502.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. Sunaga, T. Kohno, N. Yanagitani, H. Sugimura, H. Kunitoh, T. Tamura, Y. Takei, S. Tsuchiya, R. Saito, and J. Yokota
Contribution of the NQO1 and GSTT1 Polymorphisms to Lung Adenocarcinoma Susceptibility
Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 730 - 738.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
N. Yanagitani, T. Kohno, N. Sunaga, H. Kunitoh, T. Tamura, S. Tsuchiya, R. Saito, and J. Yokota
Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1
Carcinogenesis, July 1, 2002; 23(7): 1177 - 1183.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
E. Brambilla, W.D. Travis, T.V. Colby, B. Corrin, and Y. Shimosato
The new World Health Organization classification of lung tumours
Eur. Respir. J., December 1, 2001; 18(6): 1059 - 1068.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.